Ferrite Nanocrystal Synthesis via Thermal Decomposition

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for synthesizing ferrite nanocrystals, such as sol-gel and co-precipitation techniques, result in low specific absorption rate (SAR) values and poor reproducibility, leading to inefficient hyperthermia treatments due to polydispersity and limited control over size and shape, which is exacerbated by the need for solubility in polar solvents for biomedical applications.

Innovation Solution

A method involving the thermal decomposition of ferrite precursors in the presence of a ligand and a solvent mixture of ethers and high-boiling aliphatic hydrocarbons, allowing for controlled size and shape synthesis with a narrow granulometric distribution, and subsequent transfer to polar solvents using ligand exchange techniques.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of manufacture

If sol-gel or co-precipitation techniques are used to prepare ferrite nanocrystals, then the synthesis is simple and can be performed in large amounts, but the nanocrystals exhibit low SAR values, high polydispersity, and poor control over size and shape

Engineering Contradiction:
Improvesynthesis simplicityVSAvoidsize and shape control
Core Design Contradiction:
Ease of manufactureVSManufacturing precision

Solution Approach 1:

The patent employs thermal decomposition at controlled temperatures (200-400°C) with precise heating rates (1-10°C/min) to achieve monodisperse nanocrystals with controlled sizes (10-100 nm). The use of specific ligands (oleic acid, oleylamine) and their concentrations are optimized to control particle growth and morphology, transforming the simple but imprecise sol-gel method into a precision synthesis approach that maintains ease of manufacture while achieving superior size and shape control.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent uses composite surfactant systems combining multiple components (oleic acid, oleylamine, and sometimes additional ligands) to achieve simultaneous control over nucleation, growth, and stabilization of nanocrystals. This composite approach allows precise control of size and shape while maintaining simple synthesis procedures, resolving the contradiction between ease of manufacture and manufacturing precision.

Inventive Principle:
Principle #40Composite materials

2Power

If higher doses and frequencies are used to overcome low SAR values in superparamagnetic nanoparticles, then thermal power increases, but the safety limit H·f is exceeded

Engineering Contradiction:
Improvethermal powerVSAvoidbiological safety
Core Design Contradiction:
PowerVSObject-affected harmful factors

Solution Approach 1:

The patent achieves high SAR values by precisely controlling nanocrystal size (10-100 nm range) and composition during synthesis. The thermal decomposition method produces monodisperse particles with optimal sizes that maximize magnetic moment and SAR. By changing the size parameter during synthesis rather than increasing post-synthesis dosage or frequency, the patent achieves high thermal power while staying within biological safety limits.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent replaces the approach of increasing external field parameters (H and f) to increase power with an internal modification of the nanoparticle properties themselves. By optimizing size, composition, and magnetic moment during synthesis, the nanoparticles inherently generate higher SAR values, substituting the need for high-dose/high-frequency external fields with improved intrinsic material properties.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

3Reliability

If ferrite nanocrystals are synthesized with narrow granulometric distribution, then SAR values and reproducibility improve, but the synthesis complexity increases

Engineering Contradiction:
ImprovereproducibilityVSAvoidsynthesis complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent uses preliminary ligand adsorption on metal precursors before thermal decomposition to control nucleation and growth. The ligands (oleic acid, oleylamine) are pre-mixed with precursors to form stable complexes that decompose uniformly during heating, ensuring monodisperse nanocrystals. This preliminary action simplifies the overall process by built-in control mechanisms rather than requiring complex post-synthesis separation or purification steps.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent employs organic ligands as intermediary agents during thermal decomposition. These ligands mediate the decomposition process by controlling nucleation rates, growth kinetics, and particle stabilization. The intermediary ligands enable simple one-pot synthesis while achieving narrow size distributions and high reproducibility, avoiding the need for complex multi-step procedures.

Inventive Principle:
Principle #24Intermediary (Mediator)

4Length of moving object

If superparamagnetic nanoparticles smaller than 12-14 nm are used, then injectability is improved, but SAR values decrease dramatically

Engineering Contradiction:
Improveparticle sizeVSAvoidSAR value
Core Design Contradiction:
Length of moving objectVSPower

Solution Approach 1:

The patent systematically explores and optimizes the size parameter within the 10-100 nm range, identifying that monodisperse particles of 20-40 nm provide optimal balance between injectability and SAR values. The thermal decomposition method enables precise size control at these critical dimensions, achieving high SAR values at sizes suitable for biomedical applications, resolving the size-SAR trade-off through parameter optimization.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The method produces ferrite nanocrystals with high SAR values and improved reproducibility, enabling effective hyperthermia treatments and enhanced biocompatibility by maintaining high SAR values in both solution and biological tissues, while ensuring stability and solubility in polar environments.

Implementation Method 1

A method involving the thermal decomposition of ferrite precursors in the presence of a ligand and a solvent mixture of ethers and high-boiling aliphatic hydrocarbons

Methodology Applied
Scientific EffectThermal decomposition: Thermolysis

Implementation Method 2

The generation of heat is derived either from hysteresis losses or relaxation processes (Neel or Brown)

Methodology Applied
Scientific EffectHysteresis losses: Magnetic Hysteresis

Implementation Method 3

magnetic nanoparticles through exposure of the latter to an oscillating magnetic field

Methodology Applied
Scientific EffectMagnetic field exposure: Magnetic Field

Data Source

PatentEP2834195B1A process for preparing ferrite nanocrystals
Publication Date: 2018.05.02 FOND INST ITAL DI TECH
  • EP2834195B1 patent drawingFigure 1~2
  • EP2834195B1 patent drawingFigure 3A~4
  • EP2834195B1 patent drawingFigure 5~7C

AI summary

Method for producing iron-based ferrite nanocrystals, where the ferrite is selected from iron oxides and iron/cobalt or iron/manganese mixed salts, by thermal decomposition of one or more precursors of the ferrite, consisting of an organic salt of the metal or metals constituting the ferrite of interest, comprising the operation of heating a solution comprising said precursor(s) in the presence of a surfactant and of a non-aqueous organic solvent comprising an ether, at temperature sufficient to cause thermal decomposition of said precursor, characterized in that the solvent further comprises a saturated or unsaturated, linear or branched aliphatic hydrocarbon, liquid at temperatures above 45°C and having a boiling point above the boiling point of the ethereal solvent.